Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Virios rapeutics

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2022

12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Monday's Intraday Session

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Virios Therapeutics: Q1 Earnings Insights

Virios Therapeutics (NASDAQ:VIRI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Preview: Virios Therapeutics's Earnings

Virios Therapeutics (NASDAQ:VIRI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Virios Therapeutics will report an earnings per share (EPS) of $-0.53.

A Preview Of Virios Therapeutics's Earnings

Virios Therapeutics (NASDAQ:VIRI) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts estimate that Virios Therapeutics will report an earnings per share (EPS) of $-0.67.

A Fireside Chat with Greg Duncan - CEO of Virios Therapeutics

inkl

Read news from The Economist, FT, and more,
with one subscription

Organisations

Western Digital

Norwegian Cruise Line

B of A Securities

PayPal Holdings

Change Healthcare

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play